Robust interindividual variation in pain sensitivity has been observed, and recent evidence suggests that some of the variability may be genetically mediated. Our previous data revealed significantly higher pressure pain thresholds among individuals possessing the minor G allele of the A118G SNP of the mu-opioid receptor gene (OPRM1) compared with those with 2 consensus alleles. Moreover, ethnic differences in pain sensitivity have been widely reported. Yet, little is known about the potential interactive associations of ethnicity and genotype with pain perception. This study aimed to identify ethnic differences in OPRM1 allelic associations with experimental pain responses. A total of 247 healthy young adults from three ethnic groups (81 African Americans; 79 non-white Hispanics; and 87 non-Hispanic whites) underwent multiple experimental pain modalities (thermal, pressure, ischemic, cold pressor). Few African Americans (7.4%) expressed the rare allele of OPRM1 compared to non-Hispanic whites and Hispanics (28.7% vs. 27.8%, respectively). Across the entire sample, OPRM1 genotype did not significantly affect pain sensitivity. However, analysis in each ethnic group separately revealed significant genotype effects for most pain modalities among non-Hispanic-whites (P < .05) but not Hispanics or African Americans. The G allele was associated with decreased pain sensitivity among whites only; a trend in the opposite direction emerged in Hispanics. The reasons for this dichotomy are unclear; they may involve ethnic differences in haplotypic structure, or A118G may be a tag-SNP linked to other functional polymorphisms. These findings demonstrate an ethnicity-dependent association of OPRM1 genotype with pain sensitivity. Additional research is warranted to uncover the mechanisms influencing these relationships. Ó
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Introduction
Individuals vary dramatically in their presentation of and response to pain, and such variations seem to be more pronounced when considering influential factors such as ethnicity [1, 14, 21, 22] . Despite these clinically known differences, the mechanisms explicating such variability have yet to be fully understood. Emerging translational research suggests that differences in pain perception may be partially mediated by single nucleotide polymorphisms (SNPs) of identified pain genes [ Val, and mu-opioid receptor (OPRM1) A118G, the variant of focus in this study.
The A allele of the A118G polymorphism encodes asparagine at residue 40 in the protein, whereas the G allele results in a nonconservative aspartic acid substitution. G allele frequencies vary by ethnicity, ranging from 0.12 to 0.20 in whites (non-Hispanic, European descent), 0.19 to 0.24 in nonwhite Hispanics, and 0.01 to 0.04 in African Americans (http://www.ncbi.nlm.nih.gov/projects/SNP/ snp_ref.cgi?rs=1799971). The G allele has been associated with opioid analgesia, tolerance, and dependence [5,33,34,47-49,52,54].
